SAN FRANCISCO, CA --(June 24, 2020)--Quit Genius, the first technology-enabled digital clinic for multiple addictions, launched their solutions for alcohol and opioid addictions today.
In April, in response to the COVID-19 pandemic, the FDA updated the regulatory requirements for treating psychiatric disorders, including substance use disorders¹. The new guidance facilitates the treatment of substance use disorders through digital health devices, without the need for in-clinic visits.
Adding to Quit Genius’ industry-leading tobacco cessation program (52% quit rates), the company will now offer integrated support for alcohol and opioid addictions to help support patients during the pandemic and beyond. The company has pioneered a new model of physician-led care that combines counseling, medication-assisted treatment (MAT), supervised drug testing, and peer support.
The Quit Genius solution uses technology to deliver the full treatment program remotely within the privacy of a patient’s home. The program will be available to enterprise and health plan customers in the US.
“Quit Genius has delivered industry-leading health outcomes and a meaningful return on investment for our customers thus far. With COVID-19, we have seen a positive acceleration in the adoption of digital health solutions. This expansion makes Quit Genius the first digital therapeutics program for poly-substance addictions and represents a big step in our mission of helping 100 million people conquer their substance addictions.” said Quit Genius CEO, Yusuf Sherwani, MD.
“With 1 in 4 workers battling addiction and one-third of them having more than one addiction, poly-substance addictions are unfortunately common. Delivering holistic care, that treats the ‘whole person’, irrespective of their addiction or combination of addictions has been a core part of our product strategy from day one and will go a long way to enable our members to live addiction-free lives.” said Chief Product Officer, Sarim Siddiqui, MD.
About Quit Genius:
Quit Genius is the world’s first and only technology-enabled digital clinic for multiple addictions. Their evidence-based solution has industry-leading quit rates of 53% and typically results in 5X higher engagement when compared to traditional telephonic programs. Quit Genius is working with self-insured employers and health plans across the US.
Quit Genius is on a mission to leverage technology to help 100 million people quit their substance addiction.
Join our newsletter to receive updates on smarter health